{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:47:50Z","timestamp":1782982070468,"version":"3.54.5"},"reference-count":78,"publisher":"The Korean Academy of Tuberculosis and Respiratory Diseases","issue":"3","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL166231"],"award-info":[{"award-number":["R01HL166231"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24HL173667"],"award-info":[{"award-number":["K24HL173667"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["e-trd.org"],"crossmark-restriction":true},"short-container-title":["Tuberc Respir Dis"],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:p>Precision medicine aims to define subtypes of a heterogeneous disease, which can lead to more specific diagnosis, prognosis, and\/or treatment. Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease and therefore appropriate for a precision medicine approach. The idea of COPD heterogeneity has been proposed for decades, initially with subtypes of emphysema and chronic bronchitis. Modern approaches include the use of chest computed tomography (CT) scan imaging and omics biomarkers. One path forward is to start by identifying a clinical question, then try to understand the epidemiology, to describe clinical phenotypes and disease subtypes. One can then incorporate omics biomarkers to arrive at an endotype, a subtype with a shared biologic mechanism. Eosinophilic COPD and alpha-1 antitrypsin deficiency-related emphysema are endotypes that already have specific therapies. Subtypes such as patients with frequent exacerbations can be targeted with several treatments, but multiple biological processes are likely to be important. This review will highlight these approaches, using examples such as airway-predominant COPD, frequent exacerbations, and asthma-COPD overlap. These investigations have been conducted in large observational studies, including the multi-center US Genetic Epidemiology of COPD Study (COPDGene). The analyses have leveraged the wealth of data in COPDGene, including clinical information, pulmonary function tests, chest CT scans, and multi-omics such as genetics, RNA-sequencing, and proteomics. Despite these advances, there are many challenges for COPD precision medicine, such as the requirement for large studies with longitudinal outcomes and available biospecimens. Clinical trials of targeted therapies will be needed for the ultimate application of precision medicine in COPD.<\/jats:p>","DOI":"10.4046\/trd.2026.0037","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:07:02Z","timestamp":1774998422000},"page":"359-369","update-policy":"https:\/\/doi.org\/10.4046\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancing Precision Approaches to Chronic Obstructive Pulmonary Disease"],"prefix":"10.4046","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1342-4334","authenticated-orcid":true,"given":"Craig P.","family":"Hersh","sequence":"first","affiliation":[{"name":"Channing Division of Network Medicine and Division of Pulmonary and Critical Care Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2481","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmsb1503104","type":"journal-article"},{"key":"ref2","first-page":"1302","type":"journal-article","volume-title":"Emerging role of precision medicine in cardiovascular disease","author":"Leopold","year":"2018"},{"key":"ref3","volume-title":"","type":"web-resource"},{"key":"ref4","volume-title":"","type":"web-resource"},{"key":"ref5","volume-title":"","type":"web-resource"},{"key":"ref6","first-page":"478","type":"journal-article","volume-title":"New concepts in the pathobiology of chronic obstructive pulmonary disease","author":"Kim","year":"2008"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/15412550701601274","type":"journal-article"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1351so","type":"journal-article"},{"key":"ref9","first-page":"3","type":"journal-article","volume-title":"The history of COPD","author":"Petty","year":"2006"},{"key":"ref10","first-page":"1185","type":"journal-article","volume-title":"Respiratory insufficiency","author":"Dornhorst","year":"1955"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-3059","type":"journal-article"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/nejme0807387","type":"journal-article"},{"key":"ref13","first-page":"689","type":"journal-article","volume-title":"Azithromycin for prevention of exacerbations of COPD","author":"Albert","year":"2011"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(09)61255-1","type":"journal-article"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202201-0209pp","type":"journal-article"},{"key":"ref16","first-page":"205","type":"journal-article","volume-title":"Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts","author":"Bhatt","year":"2023"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2413181","type":"journal-article"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-93-3-391","type":"journal-article"},{"key":"ref19","first-page":"681","volume-title":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: report of the Medical Research Council Working Party","year":"1981","type":"journal-article"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa030287","type":"journal-article"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201803-0590oc","type":"journal-article"},{"key":"ref22","first-page":"1354","type":"journal-article","volume-title":"Improving lung function in severe heterogenous emphysema with the spiration valve system (EMPROVE): a multicenter, open-label randomized controlled clinical trial","author":"Criner","year":"2019"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00096508","type":"journal-article"},{"key":"ref24","first-page":"S130","type":"journal-article","volume-title":"Does protease-antiprotease imbalance explain chronic obstructive pulmonary disease?","author":"Lomas","year":"2016"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.5.1818","type":"journal-article"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2015.12.002","type":"journal-article"},{"key":"ref27","first-page":"360","type":"journal-article","volume-title":"Intravenous augmentation treatment and lung density in severe \u03b11 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial","author":"Chapman","year":"2015"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202305-0863oc","type":"journal-article"},{"key":"ref29","first-page":"143","type":"journal-article","volume-title":"Omics and the search for blood biomarkers in chronic obstructive pulmonary disease: insights from COPDGene","author":"Regan","year":"2019"},{"key":"ref30","first-page":"1147","type":"journal-article","volume-title":"Machine learning characterization of COPD subtypes: insights from the COPDGene Study","author":"Castaldi","year":"2020"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01359-2015","type":"journal-article"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-025-03356-w","type":"journal-article"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3109\/15412550903499522","type":"journal-article"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202301-0085oc","type":"journal-article"},{"key":"ref35","first-page":"647","type":"journal-article","volume-title":"Metabolic aging as an increased risk for chronic obstructive pulmonary disease","author":"Guo","year":"2024"},{"key":"ref36","first-page":"164","type":"journal-article","volume-title":"Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus","author":"Hersh","year":"2014"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00569-2021","type":"journal-article"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28156-4","type":"journal-article"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-023-00379-4","type":"journal-article"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202108-1819pp","type":"journal-article"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa0909883","type":"journal-article"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0114-2","type":"journal-article"},{"key":"ref43","first-page":"869","type":"journal-article","volume-title":"Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE)","author":"Vestbo","year":"2008"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0558-1","type":"journal-article"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03927-2020","type":"journal-article"},{"key":"ref46","first-page":"163","type":"journal-article","volume-title":"Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma","author":"Rhee","year":"2014"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.03.007","type":"journal-article"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062985","type":"journal-article"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-0622","type":"journal-article"},{"key":"ref50","first-page":"342","type":"journal-article","volume-title":"High hospital burden in overlap syndrome of asthma and COPD","author":"Andersen","year":"2013"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-2317","type":"journal-article"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2011.555576","type":"journal-article"},{"key":"ref53","volume-title":"","type":"book"},{"key":"ref54","first-page":"127","type":"journal-article","volume-title":"The clinical features of the overlap between COPD and asthma","author":"Hardin","year":"2011"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00436-2016","type":"journal-article"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00216013","type":"journal-article"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803466","type":"journal-article"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201010-1751oc","type":"journal-article"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2020-0382le","type":"journal-article"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)31322-8","type":"journal-article"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-11-199312010-00001","type":"journal-article"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201408-1458oc","type":"journal-article"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.15326\/jcopdf.7.1.2019.0138","type":"journal-article"},{"key":"ref64","first-page":"2037","type":"journal-article","volume-title":"Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease","author":"Yun","year":"2018"},{"key":"ref65","first-page":"398","type":"journal-article","volume-title":"Peripheral blood gene expression signatures of eosinophilic chronic obstructive pulmonary disease","author":"Yun","year":"2019"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141740","type":"journal-article"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0968-8","type":"journal-article"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.06.008","type":"journal-article"},{"key":"ref69","first-page":"491","type":"journal-article","volume-title":"Design of the subpopulations and intermediate outcomes in COPD study (SPIROMICS)","author":"Couper","year":"2014"},{"key":"ref70","first-page":"290","type":"journal-article","volume-title":"Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program","author":"Taliun","year":"2021"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)60404-8","type":"journal-article"},{"key":"ref72","first-page":"169","type":"journal-article","volume-title":"Study design and outcomes of Korean Obstructive Lung Disease (KOLD) Cohort Study","author":"Park","year":"2014"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2016.31.4.553","type":"journal-article"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201509-1722pp","type":"journal-article"},{"key":"ref75","first-page":"67","type":"journal-article","volume-title":"Prevalence of airflow limitation and emphysema in lung cancer screening populations: a systematic review and meta-analysis","author":"Choi","year":"2025"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15202562","type":"journal-article"},{"key":"ref77","first-page":"385","type":"journal-article","volume-title":"Overview of biologics targeting type 2 inflammation in respiratory disease","author":"Stevens","year":"2026"},{"key":"ref78","first-page":"250110","type":"journal-article","volume-title":"A translational view of airway epithelial dysfunction in COPD","author":"Brightling","year":"2025"}],"container-title":["Tuberculosis and Respiratory Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-trd.org\/upload\/pdf\/trd-2026-0037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-trd.org\/journal\/view.php?doi=10.4046\/trd.2026.0037","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-trd.org\/upload\/pdf\/trd-2026-0037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:18:18Z","timestamp":1782980298000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-trd.org\/journal\/view.php?doi=10.4046\/trd.2026.0037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.4046\/trd.2026.0037","relation":{},"ISSN":["1738-3536","2005-6184"],"issn-type":[{"value":"1738-3536","type":"print"},{"value":"2005-6184","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"2026-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-31","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-01","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}